| Name | Title | Contact Details |
|---|
ThromboGenics is an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic and oncology medicines. The Company`s lead product, JETREAÂŽ (ocriplasmin), has been approved by the US FDA for the treatment of symptomatic VMA and was launched in January 2013. ThromboGenics signed a strategic partnership with Alcon, a division of Novartis, for the commercialization of JETREAÂŽ outside the United States. ThromboGenics is headquartered in Leuven, Belgium, and has offices in Iselin, NJ (US) and Dublin, Ireland. The Company is listed on the NYSE Euronext Brussels exchange under the symbol THR.
Genius Therapy LLC is an early intervention agency that was founded to promote and enhance the development of infants and young children with special needs between the ages of birth to three. Our mission is for all children with special needs to achieve their maximum personal development both as individuals and as learners. At Genius Therapy, we develop programs designed specifically for each child, utilizing the principles of special instruction, applied behavioral analysis, occupational therapy and speech and language therapy.
In Harmony Inc is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cetylite Industries Inc is a Pennsauken, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Proacta is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.